Aster Capital Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-834
Closed -$5.87K 1122
2025
Q4
$5.87K Buy
834
+15
+2% +$91 ﹤0.01% 847
2025
Q3
$4.5K Sell
819
-13,604
-94% -$66.7K ﹤0.01% 811
2025
Q2
$74.6K Buy
+14,423
New +$86.4K 0.02% 548
2025
Q1
Sell
-24
Closed -$177 1490
2024
Q4
$177 Sell
24
-4,144
-99% -$29.7K ﹤0.01% 1066
2024
Q3
$29.2K Buy
+4,168
New +$25.1K 0.01% 612

Other funds holding LFST

Aster Capital Management's LFST Position: Q1 2026 in Review

Aster Capital Management sold out of Lifestance Health (LFST) in Q1 2026, closing a stake of 834 shares — an estimated $5.87K sold.

Aster Capital Management first reported a position in LFST in Q3 2024 and held it in 5 quarters. The position peaked at $74.6K in Q2 2025. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Aster Capital Management reported no remaining Lifestance Health position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 834 Lifestance Health shares in Q1 2026, an estimated $5.87K.
  • Aster Capital Management first reported a position in Lifestance Health in Q3 2024 and held it in 5 quarters.
  • Aster Capital Management's Lifestance Health position peaked at $74.6K in Q2 2025.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.